Compare, Analyse Dr. Reddys with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs TEVA PHARMA (Israel) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   TEVA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
TEVA PHARMA
Dec-13
DR. REDDYS LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,8753,137-   
Low Rs1,8882,725-   
Sales per share (Unadj.) Rs930.21,800.2-  
Earnings per share (Unadj.) Rs117.4112.5-  
Cash flow per share (Unadj.) Rs185.8258.0-  
Dividends per share (Unadj.) Rs20.0098.45-  
Dividend yield (eoy) %0.83.4 25.0%  
Book value per share (Unadj.) Rs844.41,999.7-  
Shares outstanding (eoy) m166.07848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.61.6 157.3%   
Avg P/E ratio x20.326.1 77.8%  
P/CF ratio (eoy) x12.811.4 112.8%  
Price / Book Value ratio x2.81.5 192.4%  
Dividend payout %17.087.5 19.5%   
Avg Mkt Cap Rs m395,4962,485,361 15.9%   
No. of employees `00022.044.9 48.9%   
Total wages/salary Rs m33,5620-   
Avg. sales/employee Rs Th7,032.833,965.9 20.7%   
Avg. wages/employee Rs Th1,527.90-   
Avg. net profit/employee Rs Th887.72,121.8 41.8%   
INCOME DATA
Net Sales Rs m154,4821,526,597 10.1%  
Other income Rs m3,3750-   
Total revenues Rs m157,8571,526,597 10.3%   
Gross profit Rs m31,782418,059 7.6%  
Depreciation Rs m11,348123,396 9.2%   
Interest Rs m88929,985 3.0%   
Profit before tax Rs m22,920264,678 8.7%   
Minority Interest Rs m01,202 0.0%   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m0-173,747 0.0%   
Tax Rs m3,858-3,231 -119.4%   
Profit after tax Rs m19,50095,365 20.4%  
Gross profit margin %20.627.4 75.1%  
Effective tax rate %16.8-1.2 -1,378.7%   
Net profit margin %12.66.2 202.1%  
BALANCE SHEET DATA
Current assets Rs m111,1011,031,058 10.8%   
Current liabilities Rs m58,973899,170 6.6%   
Net working cap to sales %33.78.6 390.6%  
Current ratio x1.91.1 164.3%  
Inventory Days Days7991 87.4%  
Debtors Days Days9496 98.2%  
Net fixed assets Rs m101,245498,620 20.3%   
Share capital Rs m8303,758 22.1%   
"Free" reserves Rs m139,4060-   
Net worth Rs m140,2361,695,760 8.3%   
Long term debt Rs m22,000780,583 2.8%   
Total assets Rs m224,6563,488,764 6.4%  
Interest coverage x26.89.8 272.5%   
Debt to equity ratio x0.20.5 34.1%  
Sales to assets ratio x0.70.4 157.1%   
Return on assets %9.13.6 252.6%  
Return on equity %13.95.6 247.3%  
Return on capital %14.94.9 303.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m69,5690-   
CASH FLOW
From Operations Rs m28,704243,261 11.8%  
From Investments Rs m-7,727-86,197 9.0%  
From Financial Activity Rs m-21,326-291,807 7.3%  
Net Cashflow Rs m-314-134,744 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.15 Rs / USD

Compare DR. REDDYS LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare DR. REDDYS LAB With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  TORRENT PHARMA  



Today's Market

Sensex Ends 143 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day today, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views On News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium (Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Jul 10, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - ABBOTT INDIA COMPARISON

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

MARKET STATS